Source-grounded facts extracted from CapForce Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
CapForce Inc.: The Company amended and restated its Bylaws to reflect the change in the Company’s name.
“In connection with the foregoing, the Company also amended and restated its Amended and Restated Bylaws, as amended (the “Bylaws”), to reflect the change in the Company’s name.”
CapForce Inc.: Stockholders approved an amendment to the Certificate of Incorporation changing the corporate name from OpGen, Inc. to CapForce Inc., filed with the Delaware Secretary of State on February 27, 2026, with no other changes to the certificate (effective 2026-02-27).
“At the Annual Meeting, the stockholders of the Company also approved an amendment (the “Amendment”) to the Company’s Amended and Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”), pursuant to the Name Change Proposal (as defined below) providing for a change in the Company’s corporate name from OpGen, Inc. to CapForce Inc.”
CapForce Inc. entered into Purchase Agreement with AEI Capital Ltd. valued at $12,278,703.08 (effective 2025-12-01).
“On December 1, 2025, OpGen, Inc. (the “Company”) entered into a Share Sale Agreement (the “Purchase Agreement”) with AEI Capital Ltd., a company incorporated under the laws of the British Virgin Islands and the controlling stockholder of the Company (the “Seller”), pursuant to which the Seller agreed to sell all of the issued and outstanding ordinary shares (the “Shares”) of Sun Investment Enterprises Limited, a company incorporated under the laws of the British Virgin Islands (the “Holding Company”).”
CapForce Inc. completed an acquisition involving AEI Capital Ltd. for $12,278,703.08 (closed 2025-12-01).
“limited by shares incorporated under the laws of Malaysia providing cap table management fintech platform services to customers (“iCapX”). The purchase price for the Shares was $12,278,703.08. The Company will pay the purchase price through the issuance of 2,028,867 shares of common stock at a price of $6.052 per share, which shares are expected to be issued to the”
CapForce Inc. amended Supplemental Letter to the Purchase Agreement with AEI Capital Ltd. valued at extended ability to sell shares until December 31, 2026 (effective 2025-12-17).
“On December 17, 2025, the Company and the Purchaser entered into a Supplemental Letter to the Purchase Agreement (the “Supplemental Letter”), which amended the Purchase Agreement by extending the Company’s ability to sell shares of common stock to the Purchaser until December 31, 2026.”
CapForce Inc. issued common stock to AEI Capital Ltd. for two additional tranches of common stock to the Purchaser of $3.0 million each, for an aggregate amount of $9.0 million.
“to the Purchaser, at any time prior to September 30, 2024, shares of common stock, par value $0.01 per share (the “Shares”), of the Company having an aggregate value of up to $3.0 million (the “Financing”). On October 3, 2024, the Company and the Purchaser entered into a First Amendment to the Purchase Agreement (the “First Amendment”). The First Amendment amended”
CapForce Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).
“December 19, 2024, despite OpGen, Inc. (the “Company”) regaining short-term compliance with the minimum stockholders’ equity requirement of the Nasdaq Capital Market (“Nasdaq”) pursuant to Nasdaq Listing Rule 5550(b)(1) after the deadline for such compliance granted to the Company prior to AEI Capital Ltd. acquiring a controlling interest in the Company, the Nasdaq Listing and Hearing Review Council (the “Listing Council”) affirmed the decision of the Nasdaq Hearings Panel (the “Panel”). As previously disclosed, on August 16, 2024, the Company received written notice of the Panel’s determinati”
Constance Wong Poh Yin was appointed as Director at CapForce Inc..
“On August 9, 2024, the Board of Directors (the “Board”) of OpGen, Inc. (the “Company”) voted to appoint Christian-Laurent Bonte, Victor Chua Kok Hoe, Ken Lim Zhao Qi, Ethan Low Yu Jie and Constance Wong Poh Yin as directors of the Company.”
Ethan Low Yu Jie was appointed as Director at CapForce Inc..
“On August 9, 2024, the Board of Directors (the “Board”) of OpGen, Inc. (the “Company”) voted to appoint Christian-Laurent Bonte, Victor Chua Kok Hoe, Ken Lim Zhao Qi, Ethan Low Yu Jie and Constance Wong Poh Yin as directors of the Company.”
Ken Lim Zhao Qi was appointed as Director at CapForce Inc..
“On August 9, 2024, the Board of Directors (the “Board”) of OpGen, Inc. (the “Company”) voted to appoint Christian-Laurent Bonte, Victor Chua Kok Hoe, Ken Lim Zhao Qi, Ethan Low Yu Jie and Constance Wong Poh Yin as directors of the Company.”
Victor Chua Kok Hoe was appointed as Director at CapForce Inc..
“On August 9, 2024, the Board of Directors (the “Board”) of OpGen, Inc. (the “Company”) voted to appoint Christian-Laurent Bonte, Victor Chua Kok Hoe, Ken Lim Zhao Qi, Ethan Low Yu Jie and Constance Wong Poh Yin as directors of the Company.”
Christian-Laurent Bonte was appointed as Director at CapForce Inc..
“On August 9, 2024, the Board of Directors (the “Board”) of OpGen, Inc. (the “Company”) voted to appoint Christian-Laurent Bonte, Victor Chua Kok Hoe, Ken Lim Zhao Qi, Ethan Low Yu Jie and Constance Wong Poh Yin as directors of the Company.”
CapForce Inc. underwent a change of control involving AEI Capital Ltd. for $2,550,000 (closed 2024-08-02).
“Mr. Lazar transferred 550,000 shares of Series E Stock and his right to purchase an additional 2,450,000 shares of Series E Stock to AEI Capital Ltd. (the “Purchaser”) for $2,550,000”
John Tan was appointed as Chief Executive Officer, Chairman and Director at CapForce Inc..
“the Board appointed John Tan, the designee of the Purchaser as Chief Executive Officer, Chairman and Director of the Company.”
David Natan resigned as Director at CapForce Inc..
“each of Avraham Ben-Tzvi, Matthew C. McMurdo and David Natan delivered notice of their resignation as a member of the Board”
Matthew C. McMurdo resigned as Director at CapForce Inc..
“each of Avraham Ben-Tzvi, Matthew C. McMurdo and David Natan delivered notice of their resignation as a member of the Board”
Avraham Ben-Tzvi resigned as Director at CapForce Inc..
“each of Avraham Ben-Tzvi, Matthew C. McMurdo and David Natan delivered notice of their resignation as a member of the Board”
David Lazar changed role as President at CapForce Inc..
“Mr. Lazar also agreed to continue his services to the Company in the role of President for a period of at least sixty days following the consummation of the Transaction.”
CapForce Inc.: Removed the Ownership Limitation on conversion and voting of Series E Preferred Stock (effective 2024-05-09).
“The Amendment removes such Ownership Limitation so that the shares of Series E Preferred Stock may be converted and voted without regard to such Ownership Limitation.”
CapForce Inc. entered into Agreement with Camtech Pte Ltd valued at $218,000 (effective 2024-04-23).
“On April 23, 2024, OpGen, Inc. (the “Company”) entered into a letter agreement (the “Agreement”) with Camtech Pte Ltd, a Singaporean family office (“Camtech”), for the sale of certain of the Company’s inventory and customer contracts for its Unyvero products.”
CapForce Inc. engaged Beckles & Co. as its auditor.
“on April 23, 2024, the Company engaged Beckles & Co. (“Beckles”) to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 and upcoming interim period.”
CapForce Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).
“tem 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, OpGen, Inc. (the “Company”) received notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”) as a result of failing to maintain a minimum bid price of $1.00 per share over a 30 consecutive business day period. In December 2023, Nasdaq notified the Company that the listing staff of Nasdaq had determined to delist the Company’s securities from Nasda”
CapForce Inc. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).
“April 18, 2024, the Company received a notice from Nasdaq stating that the Company was delinquent in filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Form 10-K”) and was therefore not in compliance with Nasdaq Listing Rule 5250(c)(1). The notice indicated that such delinquency serves as an additional basis for delisting the Company’s securities in addition to the failure to comply with the Minimum Bid Price Rule described above. In accordance with the notice, the Company submitted its response to the Nasdaq Hearings Panel regarding such delinquency and”
CapForce Inc.: Changes to articles of incorporation or bylaws incorporated by reference from Item 1.01; no explicit description of substantive change provided in excerpt.
“Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The disclosure required by this Item and included in Item 1.01 of this Current Report is incorporated herein by reference.”
Matthew C. McMurdo was appointed as Director at CapForce Inc..
“The then current members of the Board of Directors (the “Board”) of the Company voted to appoint Avraham Ben-Tzvi, David Natan, and Matthew C. McMurdo as new, independent directors.”
David Natan was appointed as Director at CapForce Inc..
“The then current members of the Board of Directors (the “Board”) of the Company voted to appoint Avraham Ben-Tzvi, David Natan, and Matthew C. McMurdo as new, independent directors.”
Avraham Ben-Tzvi was appointed as Director at CapForce Inc..
“The then current members of the Board of Directors (the “Board”) of the Company voted to appoint Avraham Ben-Tzvi, David Natan, and Matthew C. McMurdo as new, independent directors.”
David E. Lazar was appointed as Director at CapForce Inc..
“On March 25, 2024, prior to the transactions contemplated by the Purchase Agreement, the current members of the Board of Directors (the “Board”) approved an increase in the size of the Board and appointed Mr. Lazar to the Board.”
CapForce Inc. amended Amendment with Holder (effective 2024-02-07).
“On February 7, 2024, OpGen, Inc. (the “Company”) and a holder (the “Holder”) of certain existing warrants (the “Existing Warrants”) to purchase shares of common stock, par value $0.01 per share (the “Common Stock”), of the Company agreed to amend (the “ Amendment ”) that certain warrant inducement agreement entered into by the Company and the Holder on October 12, 2023 and amended on October 26, 2023 (as amended, the “Inducement Agreement”).”
CapForce Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
“December 6, 2023, the Company received written notification (the “December Notice”) from the Staff indicating that, based upon (i) the Company's continued non-compliance with the Minimum Bid Price Rule and (ii) the Company's inability to meet Nasdaq’s initial listing requirement for maintaining a minimum of stockholders' equity, the Staff determined that the Company was not eligible for an additional 180 day extension to meet the Minimum Bid Price Rule. As a result, the Staff determined to delist the Company's securities from Nasdaq, effective December 15, 2023, unless the Company timely reque”
CapForce Inc. terminated Standstill Agreement with European Investment Bank valued at Standstill Agreement terminated by EIB (effective 2023-11-20).
“On November 20, 2023, Curetis received a termination notice from the EIB terminating the Standstill Agreement effective as of November 20, 2023.”
CapForce Inc. reported third quarter 2023 results: revenue approximately $0.70 million.
“its third quarter 2023 financial and operating results. Third Quarter 2023 Financial Results of OpGen, Inc. · Total revenue for the third quarter of 2023 was approximately $0.70 million compared to the Company’s revenue of approximately $0.45 million in the third quarter of 2022. Total revenue for the nine months ended September 30, 2023 was approximately $2.35”
CapForce Inc. amended Inducement Agreement with a holder (the "Holder") of certain existing warrants (effective 2023-10-26).
“On October 26, 2023, OpGen, Inc. (the “Company”) and a holder (the “Holder”) of certain existing warrants (the “Existing Warrants”) to purchase shares of common stock, par value $0.01 per share (the “Common Stock”), of the Company agreed to amend that certain warrant inducement agreement (the “Inducement Agreement”) entered into by the Company and the Holder on October 12, 2023.”
CapForce Inc. entered into Inducement Agreement with a holder valued at up to approximately $11.2 million (effective 2023-10-12).
“On October 12, 2023, OpGen, Inc. (the “Company”) entered into a warrant inducement agreement (the “Inducement Agreement”) with a holder (the “Holder”) of certain existing warrants (the “Existing Warrants”)”
CapForce Inc. reported first half of 2023 results: revenue approximately $1.65 million.
“Total revenue for the first half of 2023 was approximately $1.65 million, an increase of approximately 15% compared to approximately $1.44 million in the first half of 2022”
CapForce Inc. reported second quarter of 2023 results: revenue approximately $0.7 million.
“Total revenue for the second quarter of 2023 was approximately $0.7 million compared to the company’s revenue of approximately $1.0 million in the second quarter of 2022”
CapForce Inc. entered into Standstill Agreement with European Investment Bank valued at €3 million in principal plus accumulated interest (effective 2023-07-04).
“On July 4, 2023, OpGen, Inc. (the “Company”) entered into a Standstill Agreement (the “Standstill Agreement”), by and among Curetis GmbH, the Company’s wholly owned subsidiary, as borrower (“Curetis”), the Company and Ares Genetics GmbH, the Company’s wholly owned subsidiary, as guarantors (collectively, the “Guarantors”), and the European Investment Bank, as lender (“EIB”), relating to that certain Finance Contract, originally dated December 12, 2016, as amended, by and between Curetis and EIB (the “Finance Contract”).”
CapForce Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
“June 5, 2023, OpGen, Inc. (the “Company”) received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company’s common stock failed to maintain a minimum bid price of $1.00 per share over the prior 30 consecutive business days as required by Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq’s Listing Rules, the Company has 180 calendar days to regain compliance with Nasdaq’s minimum bid price requirement. If the Company does not regain compliance within this 180-day period, the Company may be eligible to seek an additional compliance period of 180 calendar days if the”
CapForce Inc. shareholders approved Ratification of Independent Accounting Firm at the 2023-06-07 meeting.
“3. Proposal 3 - Ratification of Independent Accounting Firm . The Company’s stockholders ratified the appointment of UHY LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023, based on the following voting results: 1,347,326 votes FOR the proposal 337,259 votes AGAINST the proposal 283,615 votes ABSTAIN 0 votes Broker Non-Votes”
CapForce Inc. shareholders rejected Advisory Vote on Executive Compensation (Say on Pay) at the 2023-06-07 meeting.
“2. Proposal 2 - Advisory Vote on Executive Compensation (Say on Pay) . On a non-binding advisory basis, the Company's stockholders did not approve the compensation of the Company's named executive officers for 2022, based on the following voting results: 190,077 votes FOR the proposal 420,856 votes AGAINST the proposal 14,216 votes ABSTAIN 1,343,051 votes Broker Non-Votes”
CapForce Inc. shareholders approved Election of Directors at the 2023-06-07 meeting.
“1. Proposal 1 - Election of Directors . The election of the following named persons to serve as directors of the Company until the 2024 Annual Meeting of Stockholders or until their successors are elected and qualified. The votes cast were as follows: Nominee For Vote Withheld Broker Non-Votes William E. Rhodes, III 243,133 382,016 1,343,051 Mario Crovetto 250,803 374,346 1,343,051 R. Donald Elsey 247,334 377,815 1,343,051 Prabhavathi Fernandes, Ph.D. 247,589 377,560 1,343,051 Oliver Schacht, Ph.D. 222,773 402,376 1,343,051 Yvonne Schlaeppi 293,577 331,572 1,343,051”
CapForce Inc. reported first quarter 2023 results: revenue $0.91 million. Guidance reaffirmed.
“Total revenue for the first quarter of 2023 was approximately $0.91 million”
CapForce Inc. amended Warrant Amendment Agreement with the Investor valued at amendment to lower exercise price to $0.7785 per share and provide that warrants will not be exercis (effective 2023-05-01).
“In connection with the Offering, the Company also entered into a warrant amendment agreement (the “Warrant Amendment Agreement”) with the Investor. Under the Warrant Amendment Agreement, the Company agreed to amend certain existing warrants to purchase up to 6,396,903 shares of common stock that were previously issued in 2018, 2021, 2022 and 2023 to the Investor, with exercise prices ranging from $2.65 to $7.54 per share (the “Existing Warrants”), in consideration for their purchase of the securities in the Offering, as follows: (i) lower the exercise price of the Existing Warrants to $0.7785 per share, (ii) provide that the Existing Warrants, as amended, will not be exercisable until the receipt of stockholder approval for”
CapForce Inc. entered into Securities Purchase Agreement with a certain institutional investor valued at aggregate gross proceeds of approximately $3.5 million (effective 2023-05-01).
“On May 1, 2023, OpGen, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a certain institutional investor (the “Investor”), pursuant to which the Company agreed to issue and sell to the Investor in a best-efforts public offering (the “Offering”) (i) 605,000 shares of the Company’s common stock, par value $0.01 per share (the ‘Common Stock”), (ii) pre-funded warrants to purchase up to an aggregate of 3,890,825 shares of Common Stock (the “Pre-funded Warrants”), and (iii) common warrants to purchase up to an aggregate of 4,495,825 shares of Common Stock (the “Common Warrants” and together with the Pre-funded Warrants, the “Warrants”).”
CapForce Inc. reported full year ended December 31, 2022 results: revenue approximately $2.6 million. Guidance reaffirmed.
“Its total revenue for 2022 was approximately $2.6 million which was in line with the Company's most recent guidance.”
CapForce Inc. reported the fourth quarter of 2022 results: revenue approximately $722 thousand.
“OpGen's revenue for the fourth quarter of 2022 was approximately $722 thousand.”
CapForce Inc. engaged UHY LLP as its auditor.
“effective March 14, 2023, the Company engaged UHY LLP to serve as the Company’s independent registered public accounting firm”
CapForce Inc. dismissed CohnReznick LLP as its auditor.
“On January 19, 2023, CohnReznick LLP (“CohnReznick”), OpGen, Inc.’s (the “Company”) current independent public accounting firm, notified the Company that CohnReznick would decline to stand for re-appointment after completion of the audit for the fiscal year ended December 31, 2022. In light of such determination, the Company is currently in the process of identifying a successor independent registered public accounting firm and will disclose its”
CapForce Inc. reported year ended December 31, 2022 results: revenue approximately $2.7 million.
“Preliminary revenue for full year 2022 was approximately $2.7 million, which falls within the most recent guidance range the Company had provided in its Q3 earnings call.”
CapForce Inc. entered into Purchase Agreement with a certain institutional investor valued at aggregate gross proceeds of approximately $7.50 million (effective 2023-01-06).
“On January 6, 2023, OpGen, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with a certain institutional investor (the “Investor”)”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.